info:eu-repo/semantics/article
Sustained Neonatal Inflammation Is Associated with Poor Growth in Infants Born Very Preterm during the First Year of Life
Fecha
2019-02Registro en:
Cuestas, Eduardo; Aguilera, Belén; Cerutti, Manuel; Rizzotti, Alina; Sustained Neonatal Inflammation Is Associated with Poor Growth in Infants Born Very Preterm during the First Year of Life; Mosby-Elsevier; Journal of Pediatrics; 205; 2-2019; 91-97
0022-3476
CONICET Digital
CONICET
Autor
Cuestas, Eduardo
Aguilera, Belén
Cerutti, Manuel
Rizzotti, Alina
Resumen
To determine whether a sustained neonatal systemic inflammatory response was associated with poor postnatal growth among infants born very preterm during the first year of life. Study design: We studied prospectively 192 infants born preterm (birth weight ≤1.5 kg and gestational age ≤31 weeks). Weight, length, and head circumference were measured at birth, term, 4, and 12 months of corrected age. Serial C-reactive protein and procalcitonin were measured at 1, 3, 7, 14, and 28 days of age and averaged for each infant. A sustained neonatal systemic inflammatory response was defined as an average C-reactive protein level greater than the median for the group. Analysis was undertaken with linear mixed models. Results: Decreases in mean z scores for weight, length, and head circumference were associated with the presence of a sustained neonatal systemic inflammatory response from birth to 12 months of corrected age (β [95% CI] = ?0.282 [?0.306 to ?0.258]; ?1.899 [?2.028,?1.769]; ?0.806 [?0.910, to ?0.701], P <.001, respectively) in main effect models. This association remained significant after including interaction terms for bronchopulmonary dysplasia, neonatal sepsis, and necrotizing enterocolitis (β [95% CI] = ?0.393 [?0.520 to ?0.265]; ?2.128 [?2.754, ?1.503]; ?1.102 [?1.604, ?0.600]; P <.001; respectively) in interaction models. Conclusions: A sustained neonatal systemic inflammatory response was associated with poor postnatal growth, particularly poor linear growth. Serial C-reactive protein and procalcitonin may be useful markers for identifying infants at risk for postnatal growth failure.